Assay Detail
Binding
CHEMBL943264
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Displacement of [3H]Ro15-1788 from benzodiazepine binding site of GABAA alpha-1 V211C beta2gamma2 receptor mutant expressed in HEK293T cells
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Cell Type | HEK-293T |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| Ki | 3 | 7.59 | 8.39 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL407 | FLUMAZENIL | 4.0 | 1 | 8.39 |
| CHEMBL1522 | ESZOPICLONE | 4.0 | 1 | 7.21 |
| CHEMBL911 | ZOLPIDEM | 4.0 | 1 | 7.17 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL407 | FLUMAZENIL | Ki | = | 4.1 | nM | 8.39 |
| CHEMBL1522 | ESZOPICLONE | Ki | = | 62.4 | nM | 7.21 |
| CHEMBL911 | ZOLPIDEM | Ki | = | 67.8 | nM | 7.17 |